Inhibition of Ceramide Metabolism Sensitizes Human Leukemia Cells to Inhibition of BCL2-Like Proteins

The identification of novel combinations of effective cancer drugs is required for the successful treatment of cancer patients for a number of reasons. First, many “cancer specific” therapeutics display detrimental patient side-effects and second, there are almost no examples of single agent therape...

Descripción completa

Detalles Bibliográficos
Autores principales: Casson, Lavona, Howell, Lauren, Mathews, Lesley A., Ferrer, Marc, Southall, Noel, Guha, Rajarshi, Keller, Jonathan M., Thomas, Craig, Siskind, Leah J., Beverly, Levi J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546986/
https://www.ncbi.nlm.nih.gov/pubmed/23342165
http://dx.doi.org/10.1371/journal.pone.0054525

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546986/
https://www.ncbi.nlm.nih.gov/pubmed/23342165
http://dx.doi.org/10.1371/journal.pone.0054525

Ejemplares similares